Skip to main content
NIH funding notice PAR-14-064

Research Using Subjects From Selected Type I Diabetes Clinical Studies (Living Biobank) (DP3)

Closed on April 10, 2014.

Posted
January 7, 2014
Close date
April 10, 2014
Activity codes
Not stated on the notice page
Institutes taking part
Not stated on the notice page

Read the notice on Grants.gov · NIH Guide page

The notices it replaced

Its page was not saved, so the notices it replaced are not known.

Who won it before

1 competing award (new and renewals) from FY2014 to FY2025 under this notice and the notices it replaced: $2,452,390 in first-year total cost, median $2,452,390.

Most frequent study sections

  1. Special Emphasis Panel[ZDK1 GRB-N (O1)]1

Most frequent institutions

  1. CASE WESTERN RESERVE UNIVERSITY1
Competing awards under PAR-14-064 and the notices it replaced
FYProjectPIsInstitutionFirst-year costStudy section
2014Residual Beta Cell Function in Patients with Long-Term Type 1 Diabetes1DP3DK104438-01GUBITOSI-KLUG, ROSE ACASE WESTERN RESERVE UNIVERSITY, OH$2,452,390ZDK1

Data: Grants.gov's daily extract and NIH's notice pages and award files, in ScienceGraph release conductgrants-2026-11-10-0.1.1. An award is listed only where NIH's own record names the notice, and a PI only by NIH's profile ID. Grants.gov and NIH do not endorse ScienceDex.

ScienceDex for faculty

Your academic CV and NIH biosketch

Make your CV in your school's format and your NIH biosketch from it, then download both as Word files.